Download Cancer Biology Group

Name/Title of Group
Cancer Biology Group
Introduction
Cancer, also known as a malignant tumor or malignant neoplasm, is a group of diseases
involving abnormal cell growth with the potential to invade or spread to other parts of the body.
In 2012 about 14.1 million new cases of cancer occurred globally (not including skin cancer
other than melanoma. It caused about 8.2 million deaths or 14.6% of all human deaths. The most
common types of cancer in males are lung cancer, prostate cancer, colorectal cancer, and
stomach cancer, and in females, the most common types are breast cancer, colorectal cancer,
lung cancer, and cervical cancer.
This research group is mainly focused on cancers with special emphasis on Breast Cancer,
Hepatocellular Carcinoma and other solid tumors. The projects have been designed with the
ultimate aim of therapeutic interventions against different cancers through cytokines, ascorbic
acid and other drugs.
Research Areas
1.
2.
3.
4.
5.
Viral etiology of breast cancer
Hepatitis B cellular carcinoma
Mouse Memory Tumor Virus
Identification of novel mutations in ß-thalassemia
Epigenetic alterations in ultraviolet-induced carcinogenesis
Group Members
S#
Name
Experience
1
Dr. Hajra Sadia
PhD, NIBGE, Faisalabad, Pakistan.
Specialization: Immune Modulation of
Leukemia
Research Interests:
Tel : +92-51-9085-6129
[email protected]
2
Dr. Rumeza Hanif
PhD: Biochemistry, University College London,
UK.
Specialization: Biochemistry (Cancer Genetics
& Biometal Transport)
Research Interests:
Tel : +92 51 9085 6155
[email protected]
Research Facilities Available
s#
1.
2.
3.
4.
5.
6.
Description
Gel electrophoresis
Safety cabinet
Controlled temperature incubator
Thermal Cycler
Cold storage
Multiplex reader
Collaborations
S#
1.
Description
University of California, San Diego, USA
Research Projects
S#
1.
Description
Hepatitis B Virus-Associated Hepatocellular Carcinoma in Pakistan. 2010-2014. Pak-US
Science and Technology Cooperative Program.
Contact of Focal Person
Dr. Hajra Sadia
Tel : +92-51-9085-6129
[email protected]
[email protected]